Salutations FPC members,
First, a look at a new mitochondrial enzyme target for those failing treatment. The process of ferroptosis can lead to cancer cell death and inhibit tumor growth, but a mitochondrial enzyme (DHODH) can block that process. Researchers have found that using brequinar, a drug being studied for possible use against CoVid-19 and AML--see below:
apnews.com/press-release/bu...
The study for targeting DHODH showed even greater efficacy when used with sulfasalazine, a drug with some efficacy against PCa. Brequinar should complete Phase II trials by June, and is a drug to watch in treating different cancers. A possible game changer drug. The article below:
sciencedaily.com/releases/2...
Next, a clinical trial worth looking at for PCa patients that are oligometastatic is the Metacure trial. Being done in several locations, the trial looks at using ADT plus apalutamide and possibly abiraterone prior to removing the prostate. They do have a post prostatectomy cohort as well. The trial includes lymph node removal for suspicious nodes and SBRT for osseous lesions in an attempt to shoot for a cure.
An article on the trial from Cleveland Clinic:
consultqd.clevelandclinic.o...
Information on the trial which is still recruiting. Locations include MSK-NY, Cleveland Clinic, Northwestern-Chicago, and DFCI--Boston.
clinicaltrials.gov/ct2/show...
I love the smell of Science in the morning....smells like victory...
Don Pescado